Literature DB >> 28944836

Aberrant promoter methylation of multiple genes in VSMC proliferation induced by Hcy.

Sheng-Chao Ma1, Jian-Cheng Cao1, Hui-Ping Zhang2, Yun Jiao3, Hui Zhang1, Yang-Yang He1, Yan-Hua Wang1, Xiao-Ling Yang1, An-Ning Yang1, Jue Tian1, Ming-Hao Zhang1, Xiao-Ming Yang1, Guan-Jun Lu4, Shao-Ju Jin1, Yue-Xia Jia1, Yi-Deng Jiang1.   

Abstract

Vascular smooth muscle cell (VSMC) proliferation is a primary pathological event in atherosclerosis (AS), and homocysteine (Hcy) is an independent risk factor for AS. However, the underlying mechanisms are still lagging. Studies have used the combination of methylation of promoters of multiple genes to diagnose tumors, thus the aim of the current study was to investigate the role of methylation status of several genes in VSMCs treated with Hcy. CpG islands were identified in the promoters of platelet‑derived growth factor (PDGF), p53, phosphatase and tensin homologue on chromosome 10 (PTEN) and mitofusin 2 (MFN2). Hypomethylation was observed to occur in the promoter region of PDGF, hypermethylation in p53, PTEN and MFN2, and hypomethylation in two global methylation indicators, aluminium (Alu) and long interspersed nucleotide element‑1 (Line‑1). This was accompanied by an increase in the expression of PDGF, and reductions of p53, PTEN and MFN2, both in mRNA and protein levels. An elevation of S‑adenosylmethionine (SAM) and a reduction of S‑adenosylhomocysteine (SAH) and the SAM/SAH ratio were also identified. In conclusion, Hcy impacted methylation the of AS‑associated genes and global methylation status that mediate the cell proliferation, which may be a character of VSMCs treated with Hcy. The data provided evidence for mechanisms of VSMCs proliferation in AS induced by Hcy and may provide a new perspective for AS induced by Hcy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28944836     DOI: 10.3892/mmr.2017.7521

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

1.  Clinical value and expression of Homer 1, homocysteine, S-adenosyl-l-homocysteine, fibroblast growth factors 23 in coronary heart disease.

Authors:  Zhixin Zhang; Lin Wang; Yu Zhan; Cui Xie; Yang Xiang; Dan Chen; You Wu
Journal:  BMC Cardiovasc Disord       Date:  2022-05-12       Impact factor: 2.174

2.  High Throughput Screen Identifies the DNMT1 (DNA Methyltransferase-1) Inhibitor, 5-Azacytidine, as a Potent Inducer of PTEN (Phosphatase and Tensin Homolog): Central Role for PTEN in 5-Azacytidine Protection Against Pathological Vascular Remodeling.

Authors:  Keith A Strand; Sizhao Lu; Marie F Mutryn; Linfeng Li; Qiong Zhou; Blake T Enyart; Austin J Jolly; Allison M Dubner; Karen S Moulton; Raphael A Nemenoff; Keith A Koch; Daniel V LaBarbera; Mary C M Weiser-Evans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-06-25       Impact factor: 8.311

3.  Effects of Kindlin-2 on proliferation and migration of VSMC and integrinβ1 andβ3 activity via FAK-PI3K signaling pathway.

Authors:  Xiaolin Wu; Fang Bian; He Hu; Tongjian Zhu; Chenyu Li; Qing Zhou
Journal:  PLoS One       Date:  2020-06-30       Impact factor: 3.240

4.  Aberrant MFN2 transcription facilitates homocysteine-induced VSMCs proliferation via the increased binding of c-Myc to DNMT1 in atherosclerosis.

Authors:  Long Xu; Hongyi Hao; Yinju Hao; Guo Wei; Guizhong Li; Pengjun Ma; Lingbo Xu; Ning Ding; Shengchao Ma; Alex F Chen; Yideng Jiang
Journal:  J Cell Mol Med       Date:  2019-05-18       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.